Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Bioequivalence: Overview01:16

Bioequivalence: Overview

1.0K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
1.0K
Clinical Applications of Epidermal Stem Cells01:19

Clinical Applications of Epidermal Stem Cells

2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

2.4K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.4K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

716
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
716
Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

2.5K
The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
2.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Characterization of the Relationship Between Field Cancerization and Number of Actinic Keratoses.

Journal of cutaneous medicine and surgery·2025
Same author

Low Incidence of Oral Squamous Cell Carcinoma in Patients With Oral Lichen Planus on Sustained Anti-Inflammatory Therapy: A Single-Centre Retrospective Study of 273 Patients.

Journal of cutaneous medicine and surgery·2025
Same author

A Retrospective Study of Pediatric Allergic Contact Dermatitis from 2017-2022.

Dermatology and therapy·2025
Same author

Effectiveness of tacrolimus solution utilizing soaked gauze for the treatment of genital lichen planus: a retrospective case series of 10 patients.

Archives of dermatological research·2024
Same author

Metabolic laboratory abnormalities in patients with confluent and reticulated papillomatosis: a retrospective chart review.

Archives of dermatological research·2024
Same author

Patient and provider-directed adjunct diagnostic tools in the detection of skin cancer.

Dermatology online journal·2024
Same journal

A Novel Retinoid and Salicylic Acid Topical Treatment for Moderate-Severe Acne.

Journal of drugs in dermatology : JDD·2026
Same journal

INDIVIDUAL ARTICLE: Efficacy of a Dual-Serum Cosmetic System in Women With Female Pattern Hair Loss.

Journal of drugs in dermatology : JDD·2026
Same journal

A Randomized Controlled Trial Analyzing the Likeability, Usability, and In-Use Efficacy of Mineral Sunscreens Across Diverse Skin Tones.

Journal of drugs in dermatology : JDD·2026
Same journal

Safety and Effectiveness of Two Reconstitution Volumes of Poly-L-Lactic Acid for Correction of Décolletage Wrinkles.

Journal of drugs in dermatology : JDD·2026
Same journal

Randomized Controlled Study of Bacteriophages in Acne Reveals Efficacy and Novel Mechanism for Promoting Long-Term Skin Health.

Journal of drugs in dermatology : JDD·2026
Same journal

Efficacy and Safety of Clascoterone Cream 1% and Adapalene Gel 0.3% in Patients With Acne.

Journal of drugs in dermatology : JDD·2026
See all related articles

Related Experiment Video

Updated: Jun 29, 2025

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

17.8K

Dermatologists' Perspectives on Biosimilars.

Priscila Arellano Zameza, Christina Kontzias, Keith Flanders

    Journal of Drugs in Dermatology : JDD
    |April 2, 2024
    PubMed
    Summary
    This summary is machine-generated.

    Dermatologists show reluctance in prescribing biosimilars, with many citing safety and efficacy concerns. Educational initiatives are needed to improve the adoption of these safe and effective biologic agents in dermatology.

    More Related Videos

    Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
    05:38

    Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

    Published on: May 16, 2025

    64
    Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale
    08:49

    Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale

    Published on: May 28, 2021

    11.1K

    Related Experiment Videos

    Last Updated: Jun 29, 2025

    In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
    07:25

    In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

    Published on: May 4, 2017

    17.8K
    Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus
    05:38

    Dermoscopy Aids in the Diagnosis of Discoid Lupus Erythematosus

    Published on: May 16, 2025

    64
    Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale
    08:49

    Cultivating a Three-dimensional Reconstructed Human Epidermis at a Large Scale

    Published on: May 28, 2021

    11.1K

    Area of Science:

    • Dermatology
    • Pharmacology
    • Health Services Research

    Background:

    • Biosimilars are FDA-approved biologic agents with no clinical difference from reference biologics.
    • In dermatology, biosimilars are approved for psoriasis and hidradenitis suppurativa treatment.
    • Dermatologists are hesitant to prescribe biosimilars compared to other specialists.

    Purpose of the Study:

    • To characterize current dermatologists' perspectives on biosimilar adoption.
    • To identify barriers to biosimilar prescribing in dermatology.

    Main Methods:

    • A 27-question survey was emailed to dermatologists.
    • Data was collected between September and October 2022.

    Main Results:

    • 20% of dermatologists would not prescribe a biosimilar for an FDA-approved indication.
    • Key barriers include concerns about safety and efficacy (61%) and interchangeability laws (24%).
    • Only 35% felt knowledgeable about biosimilar interchangeability.

    Conclusions:

    • Biosimilars are safe and effective for approved dermatological conditions and can reduce patient costs.
    • Dermatologist unfamiliarity may lead to patients not being offered biosimilar therapy.
    • Educational initiatives on biosimilar safety, efficacy, and interchangeability are recommended.